Skip to main content

SUMMIT SECURITIES GROUP LLC

Broker-Dealer

Position in MRNA — Moderna, Inc.

CIK 1531593 NEW YORK, NY

Position in MRNA

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$82,600
+$67,354 QoQ
Shares Held
1,626
+214.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Dec 31, 2023
CallValue
$1,511,640
CallShares
15,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUMMIT SECURITIES GROUP LLC holds $1,851,878 across 25 Biotechnology names. MRNA ranks #3 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 MRNA
Moderna, Inc.
This page
1,626 $82,600

All Filings in MRNA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $82,600 1,626
2025-12-31 $15,246 517
2025-09-30 $15,394 596
2025-06-30 $6,318 229
2024-06-30 $6,056 51
2023-12-31 $1,511,640 15,200
2023-12-31 $3,082 31
2023-09-30 $103,290 1,000
2023-09-30 $107,731 1,043
2023-06-30 $68,161 561
2023-06-30 $121,500 1,000
2022-09-30 $172,172 1,456
2022-03-31 $310,240 1,801
2021-06-30 $2,349 10
2021-06-30 $2,349 10
2020-12-31 $1,274,534 12,200
2020-12-31 $19,326 185